The Production of Heparin Cofactor li Is Not Regulated by Inflammatory Cytokines in Human Hepatoma Cells: Comparison with Plasminogen Activator Inhibitor Type-1

Chisato Kolke; Yumiko Hayakawa; Kenji Niiya; Nobuo Sakuragawa; Hideo Sasaki

doi:10.1055/s-0038-1650264

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1996; 75(02): 298-302
DOI: 10.1055/s-0038-1650264

Original Article

Schattauer GmbH Stuttgart

The Production of Heparin Cofactor li Is Not Regulated by Inflammatory Cytokines in Human Hepatoma Cells: Comparison with Plasminogen Activator Inhibitor Type-1

Chisato Kolke

¹The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

²Third Department of Internal Medicine, Faculty of Medicine, Yamagata University, Yamagata, Japan

,

Yumiko Hayakawa

¹The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

,

Kenji Niiya

¹The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

,

Nobuo Sakuragawa

¹The Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

,

Hideo Sasaki

²Third Department of Internal Medicine, Faculty of Medicine, Yamagata University, Yamagata, Japan

› Institutsangaben

Abstract

als PDF herunterladen

Summary

Using the Northern blot technique, we screened 6 human hepatoma cell lines to investigate the regulation mechanism of heparin cofactor II (HCII) biosynthesis. We found that HuH-7 and Hep G2 cells constitutively expressed the HC II gene. In conditioned medium, HuH-7 cells constantly produced HC II that was functionally active and formed a complex with thrombin in the presence of dermatan sulfate. HC II is thought be an acute phase reactant, and, therefore, we examined the effects of the major inflammatory cytokines, IL-6, IL-1β, and TNF-α, on the regulation of HC II production in HuH-7 and Hep G2 cells. In HuH-7 cells, the antigen and mRNA levels of plasminogen activator inhibitor type-1 (PAI-1), an acute phase protein produced by hepa-tocytes, were increased in response to stimulation with either IL-6 or IL-1 (3 or both, but HC II antigen and mRNA levels were not changed by the same stimulation. Even when Hep G2 cells were treated with a combination of three cytokines, IL-6, IL-1β, and TNF-α, HC II antigen and mRNA levels were not changed; however, PAI-1 antigen and mRNA levels were clearly increased. These results suggest that the production of HC II in hepatoma cells is not regulated by the major inflammatory mediators, IL-6, IL-iβ, and TNF-α.

PDF (407 kb)

Referenzen

References
1 Tollefsen DM, Majerus DW, Blank MK. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem 1982; 257: 2162-2169
2 Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6716
3 Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM. Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochem 1988; 27: 752-759
4 Jaffe EA, Armellino D, Tollefsen DM. Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line. Biochem Biophys Res Commun 1985; 132: 368-374
5 Sandset PM, Andersson TR. Coagulation inhibitor levels in pneumonia and stroke: changes due to consumption and acute phase reaction. J Intern Med 1989; 225: 311-316
6 Toulon P, Vitoux JF, Fiessinger JN, Sicard D, Aiach M. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis. Blood Coagulation and Fibrinolysis 1991; 2: 435-439
7 Kario K, Matsuo T, Kobayashi H. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III. Thromb Res 1992; 66: 489-498
8 Bertina RM, van der Linden IK, Engesser L, Muller HP, Brommer EJ. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost 1987; 57: 196-200
9 Morrone G, Ciliberto G, Oliviero S, Arcone R, Dente L, Content J, Cortese R. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem 1988; 263: 12554-12558
10 Le J, Vilcek J. Interleukin A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588-602
11 Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636
12 Gauldie J, Sauder DN, McAdam KP, Dinarello CA. Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunol 1987; 60: 203-207
13 Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR. Pretransla-tional modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 1985; 162: 930-942
14 Perlmutter DH, Dinarello CA, Punsal PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986; 78: 1349-1354
15 Andus T, Geiger T, Hirano T, Kishimoto T, Heinrich PC. Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Eur J Immunol 1988; 18: 739-746
16 Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 1989; 143: 1163-1167
17 Mackiewicz A, Ganopathi MK, Schultz D, Brabence A, Weinstein J, Kelly MF, Kushner I. Transforming growth factor (3j regulates production of acute-phase proteins. Proc Natl Acad Sci USA 1990; 87: 1491-1495
18 Magielska-Zero D, Bereta J, Czuba-Pelech B, Pajdak W, Gauldie J, Koj A. Inhibitory effect of human recombinant interferon gamma on synthesis of acute phase proteins in human hepatoma Hep G2 cells stimulated by leukocyte cytokines, TNF alpha and IFN-beta 2/BSF-2/IL-6. Biochem Int 1988; 17: 17-23
19 Baumann H, Richards C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 1987; 139: 4122-4128
20 Juhan-Vague I, Aillaud MF, de Cock F, Philip-Joet C, Amaud C, Serradimigni A, Collen D. The fast-acting inhibitor of tissue plasminogen activator is an acute phase reactant protein. In: Progress in Fibrinolysis.. Davidson JF, Donati MB, Coccheri S, eds. Churchill-Livingstone, Edinburgh 1985: 146
21 de Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voom GP, Lambers JWJ, van Mourik JA, Hack CE. PAI-1 synthesis in the human hepatoma cell line Hep G2 is increased by cytokines - Evidence that the liver contributes to acute phase behavior of PAI-1. Thromb Haemost 1991; 65: 181-185
22 Arndt A, Murphy P, Hart D. Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-identification, characterization and regulation by inflammatory mediators. Biochem Biophys Acta 1992; 1138: 149-156
23 Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T. Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Thromb Res 1984; 36: 633-642
24 Hayakawa Y, Tazawa S, Ishikawa T-I, Niiya K, Sakuragawa N. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts. Thromb Haemost 1995; 74: 704-710
25 Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858-3863
26 Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyake K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gann 1984; 75: 151-158
27 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Mannual, Second Edition: Cold Spring Harbor. Laboratory Press 1989 7. 19-17
28 Hayakawa Y, Hayashi T, Niiya K, Sakuragawa N. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps. Blood Coagul Fibrinolysis 1995; 6: 643-649
29 Lucore CL, Fujii S, Wun TC, Sobel BE, Billadello JJ. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem 1988; 263: 15845-15848
30 Vigano S, Mannucci PM, D’Angelo A, Gensini GF, Rostagno C, Neri Semeri GG. Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes. Thromb Haemost 1984; 52: 263-266
31 Selinger MJ, McAdam KP, Kaplan MM, Sipe JD, Vogel SN, Rosenstreich DL. Monokine-induced synthesis of serum amyloid A protein by hepa-tocytes. Nature 1980; 285: 498-500
32 Baumann H, Jahreis GP, Sauder DN, Koj A. Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J Biol Chem 1984; 259: 7331-7342
33 Herzog R, Lutz S, Blin N, Marasa JC, Blinder MA, Tollefsen DM. Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22qll. Biochemistry 1991; 30: 1350-1357
34 Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 1986; 103: 787-793
35 Fowlkes DM, Mullis NT, Comeau CM, Crabtree GR. Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5 flanking regions. Proc Natl Acad Sci USA 1984; 81: 2313-2316
36 Adrian GS, Korinek BW, Bowman BH, Yang F. The human transferrin gene: 5 region contains conserved sequences which match the control elements regulated by heavy metals, glucocorticoids and acute phase reaction. Gene 1986; 49: 167-175
37 Hoffman M, Pratt CW, Brown RL, Church FC. Heparin cofactor II-pro-teinase reaction products exhibit neutrophil chemoattractant activity. Blood 1989; 73: 1682-1685
38 Church FC, Pratt CW, Hoffman M. Leukocyte chemoattractant peptides from the serpin heparin cofactor II. J Biol Chem 1991; 266: 704-709